JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Home
Signaling Pathways

Signaling Pathways

A8617 CCT128930 HCl

Target: Akt

Summary: AKT inhibitor

insoluble in H2O; ≥17.1 mg/mL
B2290 Beta-Lapachone

Target: Topoisomerases

Summary: DNA topoisomerase I inhibitor,selective

insoluble in H2O; ≥10.85 mg/mL
B1119 Efavirenz

Target: HIV-1 reverse transcriptase

Summary: Reverse transcriptase inhibitor

insoluble in H2O; ≥15.55 mg/mL
B1511 Mifepristone
3 Citation

Target: Progesterone Receptors|Glucocorticoid Receptors

Summary: Progesterone receptor antagonist

≥21.48 mg/mL
B4890 HPOB
1 Citation

Target: Histone Deacetylases (HDACs)

Summary: HDAC6 inhibitor, potent and selective

≥31.4 mg/mL
B4900 Indoximod (NLG-8189)

Summary: Indoleamine 2,3-dioxygenase (IDO) pathway inhibitor

insoluble in DMSO; insoluble in EtOH; ≥1.12 mg/mL
B2157 Cabazitaxel
3 Citation

Target: Microtubule/Tubulin

Summary: Microtubule associated inhibitor

≥22.3 mg/mL
B2266 LDE225 (NVP-LDE225,Erismodegib)
1 Citation

Target: Smoothened

Summary: Smoothened inhibitor,potent and selective

≥24.3 mg/mL
B2283 Niclosamide

Target: STAT

Summary: Inhibitor of the STAT3 signaling pathway
B1564 Ranitidine

Target: Histamine H2 Receptors

Summary: Histamine H2-receptor antagonist

≥17.54 mg/mL